
GLP-2(T) is a single-peptide research compound that acts as a dual agonist of the GIP and GLP-1 incretin receptors—two class B G-protein-coupled receptors. Characterized in the literature as an ‘imbalanced’ dual agonist, it is studied for its receptor-level pharmacology: glucose-dependent insulinotropic signaling at pancreatic β-cells and GLP-1-receptor-mediated modulation of glucagon. This compound gives researchers a single platform for exploring next-generation dual-incretin receptor science.

All products on this site are sold strictly for laboratory and scientific research use only. They are not for human or veterinary consumption and are not intended to diagnose, treat, cure, or prevent any disease.
By entering, you confirm you are at least 21 years of age and are acquiring these materials solely for legitimate research purposes.
By entering you agree to our Terms of Service and Research-Use-Only policy.